Literature DB >> 27362834

Collimator design for spatially-fractionated proton beams for radiobiology research.

Eunsin Lee1, Juergen Meyer, George Sandison.   

Abstract

Preclinical and translational research is an imperative to improve the efficacy of proton radiotherapy. We present a feasible and practical method to produce spatially-modulated proton beams for cellular and small animal research for clinical and research facilities. The University of Washington (UW) 50.5 MeV proton research beamline hosting a brass collimation system was modeled using Monte Carlo simulations. This collimator consisted of an array of 2 cm long slits to cover an area of 2  ×  2 cm(2). To evaluate the collimator design effects on dose rate, valley dose and the peak-to-valley dose ratios (PVDR) the following parameters were varied; slit width (0.1-1.0 mm), peak center-to-center distance (1-3 mm), collimator thickness (1-7 cm) and collimator location along the beam axis. Several combinations of slit widths and 1 mm spacing achieved uniform dose at the Bragg peak while maintaining spatial modulation on the beam entrance. A more detailed analysis was carried out for the case of a slit width of 0.3 mm, peak center-to-center distance of 1 mm, a collimator thickness of 5 cm and with the collimator flush against the water phantom. The dose rate at 5 mm depth dropped relative to an open field by a factor of 12 and produced a PVDR of 10.1. Technical realization of proton mini-beams for radiobiology small animal research is demonstrated to be feasible. It is possible to obtain uniform dose at depth while maintaining reasonable modulation at shallower depths near the beam entrance. While collimator design is important the collimator location has a strong influence on the entrance region PVDRs and on dose rate. These findings are being used to manufacture a collimator for installation on the UW cyclotron proton beam nozzle. This collimator will enable comparative studies on the radiobiological efficacy of x-rays and proton beams.

Entities:  

Mesh:

Year:  2016        PMID: 27362834     DOI: 10.1088/0031-9155/61/14/5378

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

Review 1.  Spatially fractionated proton minibeams.

Authors:  Juergen Meyer; John Eley; Thomas E Schmid; Stephanie E Combs; Remi Dendale; Yolanda Prezado
Journal:  Br J Radiol       Date:  2018-11-07       Impact factor: 3.039

2.  iBEX: Modular Open-Source Software for Digital Radiography.

Authors:  Altay Brusan; F Aytaç Durmaz; Alper Yaman; Cengizhan Öztürk
Journal:  J Digit Imaging       Date:  2020-06       Impact factor: 4.056

3.  Proton minibeams-a springboard for physics, biology and clinical creativity.

Authors:  F Avraham Dilmanian; Bhanu P Venkatesulu; Narayan Sahoo; Xiaodong Wu; Jessica R Nassimi; Steven Herchko; Jiade Lu; Bilikere S Dwarakanath; John G Eley; Sunil Krishnan
Journal:  Br J Radiol       Date:  2020-01-24       Impact factor: 3.039

4.  Dose Profile Modulation of Proton Minibeam for Clinical Application.

Authors:  Myeongsoo Kim; Ui-Jung Hwang; Kyeongyun Park; Dohyeon Kim; Hak Soo Kim; Sang Hyoun Choi; Jong Hwi Jeong; Dongho Shin; Se Byeong Lee; Joo-Young Kim; Tae Hyun Kim; Hye Jung Baek; Hojin Kim; Kihwan Kim; Sang Soo Kim; Young Kyung Lim
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

Review 5.  Monte Carlo methods for device simulations in radiation therapy.

Authors:  Hyojun Park; Harald Paganetti; Jan Schuemann; Xun Jia; Chul Hee Min
Journal:  Phys Med Biol       Date:  2021-09-14       Impact factor: 4.174

Review 6.  FLASH and minibeams in radiation therapy: the effect of microstructures on time and space and their potential application to protontherapy.

Authors:  Alejandro Mazal; Yolanda Prezado; Carme Ares; Ludovic de Marzi; Annalisa Patriarca; Raymond Miralbell; Vincent Favaudon
Journal:  Br J Radiol       Date:  2020-02-12       Impact factor: 3.039

7.  Heavy Ion Minibeam Therapy: Side Effects in Normal Brain.

Authors:  John G Eley; Catherine W Haga; Asaf Keller; Ellis M Lazenby; Charles Raver; Adam Rusek; Farrokh Avraham Dilmanian; Sunil Krishnan; Jaylyn Waddell
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.